Lord’s Mark Advances Breast Cancer Screening Tech to Final Trials
Lords Mark Industries Ltd · Others (Uncategorized) · 23 Sept 2026, 2:03 pm
Lord’s Mark Advances Breast Cancer Screening Tech to Final Trials Lord’s Mark Industries received Technical Committee approval to advance its AI-powered, radiation-free wearable breast cancer screening technology to final clinical trials across the US, Great Britain, and Europe, following completed India trials. Phase 2 trials targeting 98% accuracy will commence in Jan'27. Holding exclusive commercialisation rights in collaboration with C-MET, the company is pursuing CDSCO, US FDA, and European approvals. It targets trial completion by Mar'27 and a commercial launch by Apr'27, addressing a global breast cancer diagnostics market projected to reach USD 11.4B by 2033 (8.8% CAGR).
Original exchange filing (PDF)
More announcements from Lords Mark Industries Ltd
- Investor Presentation H1 · 18 Nov 2026
- Investor Meet on 19th Nov 2026 · 16 Nov 2026
- Revised Outcome of BM held on 14 Nov 2026 · 15 Nov 2026
- Revised financials for September 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14.11.2026 · 14 Nov 2026
- September 2026 results · 14 Nov 2026
- Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Board Meeting intimation .... · 14 Nov 2026
- Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years . · 03 Nov 2026
